Q&A: Hanns-Georg Klein on Adopting Next-Gen Sequencing in a Clinical Diagnostics Lab | GenomeWeb

KleinPhoto2.jpgName: Hanns-Georg Klein
Age: 53
Position: CEO and clinical pathologist and medical geneticist, Center for Human Genetics and Laboratory Medicine Dr. Klein, Dr. Rost and colleagues (since 1998) and CEO, IMGM Laboratories (since 2001), Martinsried/Munich
Experience and Education:
Co-founder, Medigenomix (now part of Eurofins), 1997

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.